Company news

EKF Diagnostics Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Investor results briefing update

March 20, 2020

Trading update and performance bonuses

November 6, 2019

Preferred Partner Arrangement with Mount Sinai

September 10, 2019

Cancellation of share options

June 11, 2019

Acquisition of further interest in Renalytix AI

April 26, 2019

Posting of AR & Accounts and Notice of AGM

April 25, 2019

US FDA approval for Quo-Test analyser

February 20, 2019

Update on McKesson US distribution agreement

January 22, 2019

Update regarding planned change of NOMAD

December 20, 2018

PDMR dealing

December 19, 2018

Purchase of own shares and PDMR Dealing

December 7, 2018

Share Buy-Back

November 14, 2018

Update regarding AIM admission of RenalytixAI

November 1, 2018

Result of RO by RenalytixAI & Fundraising Update

October 31, 2018

Update to distribution timetable

October 23, 2018

Approval of distribution of shares in RenalytixAI

October 22, 2018

Investor presentation

October 12, 2018

Launch of Restricted Offer by Renalytix AI plc

October 11, 2018

Notice of GM

September 27, 2018

Update regarding proposed IPO of Renalytix AI

August 31, 2018

DiaSpect Tm McKesson US distribution agreement

August 9, 2018

US distribution agreement for diabetes assay kit

July 24, 2018

Manufacturing partnership with Oragenics, Inc.

July 19, 2018

Exploring funding options for Renalytix AI

July 4, 2018

Update regarding Renalytix AI PLC

June 1, 2018

Licence and collaboration agreement signed

May 31, 2018

Posting of AR and Accounts & Notice of AGM

April 18, 2018

US FDA approval for Diaspect Tm

April 9, 2018

Share cancellation

December 21, 2017

Confirmation of share cancellation

November 2, 2017

Cancellation of escrow shares PDMR dealing/buyback

October 3, 2017

Reduction of capital

September 6, 2017

Trading Update & Structure Update

May 10, 2017

Annual Financial Report

April 18, 2017

Update

March 20, 2017

Change of Nominated Adviser and Broker

February 22, 2017

Appointment of Joint Broker

September 19, 2016

Grant of Options

September 12, 2016

Director Dealing

June 10, 2016

Results of Placing

June 2, 2016

Loan redemption update

April 26, 2016

Notice of AGM

April 22, 2016

Notice of loan redemption

April 15, 2016

Sale of Selah

December 23, 2015

Fundraising

December 22, 2015

Appointment of a Director

December 21, 2015

Directorate Changes

December 10, 2015

Death of Director

November 20, 2015

Consolidation of manufacturing sites

November 12, 2015

Biomarker data predicting diabetic kidney disease

November 9, 2015

← Newer news releases · Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.